Sign in
  1. Home
  2. Companies
  3. Prestige Consumer Healthcare
  4. Financial Ratios
Prestige Consumer Healthcare logo
Prestige Consumer Healthcare PBH
$ 49.79 0.08%
report update icon

Quarterly report 2027-Q1
added 08-06-2026

Prestige Consumer Healthcare Financial Ratios 2026-2009 | PBH

Brief overview of Prestige Consumer Healthcare 's market valuation

Current figures are compared with the company's own five-year history for 2021–2026.

The current valuation set is P/E 11.7x (median 16.71x), EV/EBITDA 11.06x (median 14.14x), P/S 2.04x (median 2.81x). The combined multiple level is about 30% below the company's historical norm, suggesting more cautious expectations.

Earnings yield calculated as 1/P/E is about 8.6%, showing current profit per unit of share price.

Current measures of operating quality are ROE 10.1%, ROA 5.4%, ROCE 16.4%. Capital returns look adequate and support overall financial resilience.

The cash conversion cycle lengthened from 94.9 days to 162.9 days, or 67.9 days. More cash is tied up in operations.

Conclusion

Prestige Consumer Healthcare 's high-quality returns come with historically restrained multiples. Price appears more cautious than current business efficiency.

Annual Financial Ratios Prestige Consumer Healthcare

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

P/E

 11.7 19.2 16.7 -36.8 14.9 17.2 14.5 -42.8 4.6 43.8 30.0 26.2 23.8 20.8 23.0 19.8 11.8 -

P/S

 2.0 3.6 3.1 2.7 2.8 3.0 2.1 1.6 1.5 3.4 3.7 2.9 2.9 2.2 1.9 1.7 - -

EPS

 3.9 4.3 4.2 -1.6 4.1 3.3 2.8 -0.7 6.4 1.3 1.9 1.5 1.4 1.3 0.7 0.6 0.6 -

EV (Enterprise Value)

 3.77 B 5.59 B 5.12 B 4.88 B 5.12 B 4.87 B 4.31 B 3.85 B 4.11 B 6.09 B 5.17 B 4.07 B 2.93 B 2.61 B 2.19 B 1.26 B 337 M -35.2 M

EBITDA per Share

 7.03 7.38 7.5 0.2 7.2 6.52 6.23 6.2 4.6 5.34 5.38 4.32 3.91 4.05 2.26 1.72 1.8 -

EV/EBITDA

 11.1 15.2 13.7 477.9 14.1 14.8 11.7 10.2 14.4 18.4 16.2 16.0 13.0 11.3 17.3 12.2 3.8 -

PEG

 0.02 0.03 0.02 3.93 2.04 3.41 0.03 0.39 0.01 -1.43 1.15 4.1 2.56 0.28 0.86 -2.17 - -

P/B

 1.2 2.2 2.1 2.1 1.9 2.1 1.8 1.4 1.3 3.7 4.0 3.3 3.1 2.9 2.1 1.6 - -

P/CF

 8.6 16.4 14.1 13.2 11.7 12.0 10.3 8.6 7.9 21.0 17.5 13.6 15.9 10.7 12.8 6.7 6.4 -

ROE %

 10.08 11.70 12.65 -5.69 13.02 12.12 12.15 -3.27 28.81 8.44 13.42 12.47 12.89 13.71 9.24 8.08 9.76 -

ROA %

 5.45 6.31 6.31 -2.45 5.60 4.80 4.05 -1.04 9.03 1.77 3.39 2.93 4.04 3.77 2.12 2.76 - -

ROCE %

 16.39 18.35 20.69 -1.55 20.91 21.90 8.65 8.92 5.93 6.87 9.16 8.08 11.02 11.68 6.07 7.59 23.80 -

Current Ratio

 2.2 2.2 2.0 1.8 1.8 1.7 2.4 2.4 2.5 2.1 2.3 2.0 2.1 1.7 2.3 2.0 - -

DSO

 64.7 59.5 55.8 49.6 42.7 51.3 57.0 55.7 49.4 56.6 43.1 44.9 39.4 42.8 49.8 48.2 - -

DIO

 113.6 103.9 109.6 102.6 92.1 106.5 103.1 104.1 93.1 110.5 98.3 87.6 91.4 79.5 87.3 87.6 - -

DPO

 15.4 21.0 37.1 43.0 39.8 49.9 55.4 49.1 48.2 67.1 41.2 54.6 67.3 67.8 45.6 47.6 - -

Operating Cycle

 178.3 163.4 165.4 152.2 134.8 157.8 160.1 159.8 142.5 167.1 141.4 132.5 130.9 122.3 137.1 135.7 - -

Cash Conversion Cycle

 162.9 142.4 128.3 109.1 94.9 107.8 104.7 110.7 94.3 100.0 100.1 77.9 63.6 54.4 91.5 88.1 - -

All numbers in USD currency

Quarterly Financial Ratios Prestige Consumer Healthcare

2027-Q1 2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 0.61 0.98 0.86 0.96 0.98 0.86 0.96 0.98 1.23 1.1 0.98 1.07 1.07 1.08 1.07 - 1.05 1.02 1.1 - 1 3.05 2.05 - 0.81 0.81 0.89 0.74 0.76 0.76 0.66 0.66 0.74 0.74 0.59 -0.75 5.93 0.58 0.64 0.64 0.6 0.6 0.61 -0.1 0.53 0.53 0.6 0.5 0.41 0.41 0.32 0.32 0.06 0.06 0.64 0.4 0.24 0.24 0.38 0.29 0.19 0.19 0.26 0.29

EBITDA per Share

 1.29 2.2 1.94 1.61 1.81 1.72 1.61 1.61 1.94 1.8 1.61 1.86 1.84 1.87 1.86 - 1.87 1.81 1.9 - 1.75 5.5 3.7 - 1.56 1.91 1.75 1.47 1.61 1.95 1.66 1.52 1.6 1.96 1.68 -0.43 1.69 1.54 1.65 1.49 1.33 1.66 1.58 0.23 1.21 1.52 1.54 1.19 1.11 1.32 1.02 0.82 0.8 0.98 1.17 0.97 0.93 1.12 1.15 0.87 0.47 0.62 0.69 0.54

ROE %

 8.95 9.98 9.74 9.98 10.34 11.20 12.03 12.39 13.07 12.97 13.32 14.00 13.48 13.32 13.32 9.72 13.02 20.43 24.56 21.07 24.16 23.94 16.94 9.67 12.83 13.03 13.23 12.73 12.65 12.45 12.26 11.85 5.41 28.17 28.50 29.85 37.32 15.42 16.08 16.51 11.66 11.59 11.59 12.02 16.93 16.55 16.05 14.06 12.86 9.94 6.93 10.68 12.04 14.14 16.36 14.40 13.71 13.40 13.04 11.86 12.31 2.43 3.43 4.08

ROA %

 4.58 5.28 5.17 5.33 5.43 5.93 6.34 6.44 6.55 6.30 6.27 6.38 6.17 5.97 5.74 4.14 8.32 9.83 8.44 8.44 9.62 9.44 6.56 3.66 4.72 4.64 4.54 4.21 4.14 4.09 4.02 3.88 1.84 8.87 8.63 8.67 10.59 3.64 3.97 4.22 3.17 3.11 3.06 3.14 4.32 4.06 3.77 3.45 3.40 2.77 2.16 3.16 3.42 3.96 4.47 3.68 3.33 3.53 3.74 3.88 4.44 0.90 1.23 1.40

ROCE %

 15.48 17.25 17.11 16.61 17.03 17.66 18.17 18.59 20.05 20.34 21.21 22.68 22.09 21.88 21.62 15.87 21.31 33.41 40.20 34.71 40.26 40.37 28.80 16.80 23.12 24.17 25.23 25.76 25.93 25.62 25.30 25.01 16.56 17.16 19.33 22.58 34.14 35.91 36.40 36.84 28.88 28.91 29.10 30.01 38.33 39.00 39.46 36.85 34.49 32.56 30.44 33.25 35.99 38.78 41.96 43.44 43.98 39.65 35.03 30.59 27.23 6.04 7.78 7.53

Current Ratio

 1.7 2.1 2.1 2.2 2.1 2.1 2.2 2.0 2.2 2.1 2.0 1.8 1.9 1.9 1.8 1.8 1.8 1.8 - 1.8 1.7 1.7 1.7 1.7 1.6 1.6 1.6 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.4 1.5 1.4 1.3 1.3 1.3 1.4 1.4 1.3 1.3 1.4 1.4 1.3 1.3 1.3 1.3 1.5 1.5 1.4 1.4 1.4 1.4 1.4 1.3 1.3 1.3 1.6 1.6 1.6 1.5

DSO

 64.9 62.7 61.1 65.6 62.7 61.1 62.2 57.9 52.0 53.9 56.3 54.3 53.7 50.4 53.1 - 50.2 23.0 22.9 - 46.7 15.4 20.5 - 45.5 44.8 50.5 53.6 54.2 53.9 55.9 56.9 55.6 57.5 52.3 51.9 49.9 49.5 48.3 45.7 41.5 38.2 39.0 39.3 40.2 40.3 38.4 41.7 43.0 36.2 31.0 41.1 46.2 44.9 36.9 47.0 45.1 43.9 40.2 38.2 42.8 40.0 38.1 -

DIO

 124.6 116.7 116.2 132.3 116.7 116.2 127.5 114.3 108.6 111.3 121.2 116.6 113.3 119.6 121.5 - 109.0 50.0 47.0 - 81.8 28.0 44.0 - 105.5 105.4 106.5 100.9 108.6 112.1 112.2 111.8 104.5 103.8 106.4 92.8 87.0 95.4 94.5 87.3 98.4 94.4 92.2 89.2 - - - - - - - - - - - - - - - - - - - -

DPO

 28.1 30.7 23.9 27.2 30.7 23.9 25.8 22.2 17.9 25.5 36.7 35.6 30.6 36.9 44.1 - 43.9 20.0 21.8 - 29.9 9.1 15.3 - 38.6 40.1 43.3 48.0 50.6 55.7 53.4 49.1 51.5 64.6 62.6 48.0 51.4 56.9 53.6 46.6 41.7 36.6 36.7 34.7 - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - 179.4 177.4 188.7 - 160.6 165.2 172.3 - 167.0 170.0 174.6 - 159.2 73.0 69.9 - 128.5 43.4 64.5 - 151.0 150.2 157.0 154.5 162.8 166.1 168.2 168.6 160.1 161.3 158.7 144.8 136.9 144.9 142.8 133.1 139.9 132.6 131.2 128.4 40.2 40.3 38.4 41.7 43.0 36.2 31.0 41.1 46.2 44.9 36.9 47.0 45.1 43.9 40.2 38.2 42.8 40.0 38.1 -

Cash Conversion Cycle

 - - - - 148.7 153.5 171.2 - 142.7 139.6 142.6 - 136.4 133.1 130.4 - 115.3 53.0 48.1 - 98.7 34.3 49.1 - 112.4 110.1 113.7 106.5 112.3 110.4 114.7 119.5 108.7 96.7 96.1 96.8 85.4 88.1 89.2 86.5 98.2 95.9 94.5 93.8 40.2 40.3 38.4 41.7 43.0 36.2 31.0 41.1 46.2 44.9 36.9 47.0 45.1 43.9 40.2 38.2 42.8 40.0 38.1 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Prestige Consumer Healthcare , allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Medical distribution industry

Issuer Price % 24h Market Cap Country
PPD, Inc. PPD, Inc.
PPD
 		- 0.13 % $ 16.6 B usaUSA
Cardinal Health Cardinal Health
CAH
 		$ 240.49 0.03 % $ 56.8 B usaUSA
Henry Schein Henry Schein
HSIC
 		$ 88.86 0.52 % $ 10.7 B usaUSA
McKesson Corporation McKesson Corporation
MCK
 		$ 889.12 0.15 % $ 110 B usaUSA
AmerisourceBergen Corporation AmerisourceBergen Corporation
ABC
 		- -0.23 % $ 37.5 B usaUSA
Owens & Minor Owens & Minor
OMI
 		- - $ 215 M usaUSA
Patterson Companies Patterson Companies
PDCO
 		- -0.87 % $ 3 B usaUSA